Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

ProQR Therapeutics N.V. (PRQR)

6.95 -0.2 (-2.8%)

07-19 16:00

Open:

7.15

Pre. Close:

7.15

High:

7.15

Low:

6.9

Volume:

20,281

Market Cap:

222M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

7.159 - 7.203

7.203 - 7.235

Low:

6.795 - 6.85

6.85 - 6.889

Close:

6.878 - 6.958

6.958 - 7.015

Technical analysis  (as of: 2018-07-19 4:32:09 PM)

Overall:

      

Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.

Target:

Six months: 8.70     One year: 10.16

Support:

Support1: 6.71    Support2: 6.25

Resistance:

Resistance1: 7.45    Resistance2: 8.70

Pivot:

7.03

Moving Averages:

MA(5): 7.07     MA(20): 7.08

MA(100): 4.88     MA(250): 4.36

MACD:

MACD(12,26): 0.17     Signal(12,26,9): 0.23

%K %D:

%K(14,3): 69.44     %D(3): 69.91

RSI:

RSI(14): 53.54

52-Week:

High: 7.45  Low: 2.75  Change(%): 36.3

Average Vol(K):

3-Month: 9037  10-Days 5064

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
PRQR has closed above bottom band by 41.1%. Bollinger Bands are 19.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-06-12T08:49:41-04:00
ProQR inks deal with EBRP and EBMRF to develop QR-313 for the treatment of DEB

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

31.92

Shares Float (M)

31.92

% Held by Insiders

% Held by Institutions

60.80

Shares Short (K)

132

Shares Short Prior Month (K)

Stock Financials

EPS

-1.880

EPS Est. Current Year

-2.110

EPS Est. Next Year

-1.740

EPS Est. Next Quarter

-0.520

Forward EPS

-1.749

Book Value (p.s.)

6.380

PEG Ratio

Profit Margin

Operating Margin

-4140.88

Return on Assets (ttm)

-94.7

Return on Equity (ttm)

-126.9

Qtrly Rev. Growth

82.8

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.700

Qtrly Earnings Growth

Operating Cash Flow (M)

-41.80

Levered Free Cash Flow (M)

-25.14

atoplab.com

Valuation

P/E

-3.70

P/E Growth Ratio

-0.03

P/BV

1.09

P/S

5546099712.00

P/CF

-5.31

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.